- This event has passed.
Westminster Health Forum Keynote Seminar
July 13, 2016
Westminster Health Forum Keynote Seminar:
Improving diabetes outcomes: personalisation, innovation and rolling out the
Diabetes Prevention Programme
Timing: Morning, Wednesday, 13th July 2016
Venue: Central London
Draft agenda subject to change
| 8.30 – 9.00 | Registration and coffee |
| 9.00 – 9.05 | Chair’s opening remarks
Jamie Reed MP |
| 9.05 – 9.30 | Priorities for improving diabetes outcomes
Professor Jonathan Valabhji, National Clinical Director for Obesity and Diabetes, NHS England Questions and comments from the floor |
| 9.30 – 10.00 | Early indications from the Diabetes Prevention Programme demonstrator sites and progress of the national roll out
Dr Jim O’Brien, National Programme Director, NHS Diabetes Prevention Programme, Public Health England Simon Doble, Senior Commissioning Manager, Birmingham South Central Demonstrator Site Dr Richard Mendelsohn, Clinical Head of Commissioning, Birmingham South Central Demonstrator Site Questions and comments from the floor |
| 10.00 – 10.10 | Accelerating access to diagnostics: regulation, care pathways and the future for genomic medicine
Senior representative, diagnostics |
| 10.10 – 10.20 | Innovation and the developing role of industry
Senior representative, industry |
| 10.20 – 10.30 | Challenges for keeping diabetes guidance up-to-date
Professor Stephanie Amiel, Chair, NICE Guideline Development Group for Diabetes in Adults and Professor of Diabetic Medicine, King’s College London |
| 10.30 -10.50 | Questions and comments from the floor |
| 10.50 – 10.55 | Chair’s closing remarks
Jamie Reed MP |
| 10.55 – 11.25 | Coffee |
| 11.25 – 11.35 | Chair’s opening remarks
Rt Hon Keith Vaz MP, Chair, All-Party Parliamentary Group for Diabetes |
| 11.35 – 11.50 | Case study: Integration and implementing new models of care
Senior representative, vanguard Questions and comments from the floor |
| 11.50 – 12.50 | Managing diabetes and 2020 aspirations: early diagnosis, co-morbidities and the National Diabetes Inpatient Audit
How should health professionals collaborate to reduce variations in the management of diabetes care by 2020, as set out in the NHS Mandate, and what impact will the introduction of a new scorecard system have on measuring quality of care? What more should be done to prioritise earlier diagnosis of diabetes, and what are the next steps for identifying those most at risk of developing type 2 diabetes? How can challenges around improving personalisation of care and educating patients to manage their condition be overcome? With the Public Accounts Committee reporting that the number of diabetes patients who develop complications is increasing, what more needs to be done to reduce complications and effectively manage co-morbidities? What lessons can be learnt from the National Diabetes Inpatient Audit data to improve hospital care? Robert White, Director, Health Value for Money Audit, National Audit Office Robin Hewings, Head of Policy, Diabetes UK Dr Rupert Dunbar-Rees, Founder and Chief Executive Officer, Outcomes Based Healthcare Dr Emma Wilmot, Consultant Diabetologist, Derby Teaching Hospitals NHS Foundation Trust Senior representative, primary care Questions and comments from the floor |
| 12.50 – 12.55 | Concluding remarks
Professor Jonathan Valabhji, National Clinical Director for Obesity and Diabetes, NHS England |
| 12.55 – 13.00 | Chair’s and Westminster Health Forum closing remarks
Rt Hon Keith Vaz MP, Chair, All-Party Parliamentary Group for Diabetes Sam Dolton, Associate Producer, Westminster Health Forum |
AstraZeneca has provided a sponsorship grant towards this independent programme